Citatuzumab bogatox
From Self-sufficiency
Monoclonal antibody | |
---|---|
Type | Fab fragment |
Source | Template:Infobox drug/mab source |
Target | TACSTD1 |
Identifiers | |
CAS Number | 945228-49-9 |
ATC code | none |
Chemical data | |
Formula | C3455H5371N921O1060S18 |
Molar mass | 77.3 kDa[[Script error: No such module "String".]] |
Citatuzumab bogatox (VB6-845) is a monoclonal antibody Fab fragment fused with bouganin, an ribosome inactivating protein from the plant Bougainvillea spectabilis.[1] It has undergone pre-clinical trials for the treatment of ovarian cancer and other solid tumors.[2]
References
- ↑ International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
- ↑ Viventia Biotech Inc.: VB6-845
40x30px | This monoclonal antibody-related article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Drugs that are a monoclonal antibody
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- Pages with broken file links
- Monoclonal antibody stubs